Search

everythinglearnresearchcommunity

for

Search:↓

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

KRT17 may be a new target for endometrial cancer treatment because it helps cancer cells move and form new blood vessels.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Cancer-associated fibroblasts promote tumor growth in skin cancer.

CREB, a protein that can promote cancer traits, is controlled by β-catenin in skin cancer cells.

Mice with a specific BRCA1 mutation have a higher risk of tumors, especially in the uterus and ovaries.

Dabrafenib can cause skin growths and sometimes low-grade skin cancer.

More research and guidelines are needed for managing prostate cancer in people with high-risk genetic mutations.

Colorectal cancer cells can adapt without losing their traits or drug sensitivity.

Keratin 10 end domains may increase skin cancer risk by reducing cell death.

Blocking the JAK/STAT pathway may help reduce skin sensitivity in Xeroderma pigmentosum.

The hair keratin gene KRT81 is found in both normal and breast cancer cells and helps them invade surrounding tissues.

Markers CRABP1, Nestin, and Ephrin B2 are present in skin cancer environments and may influence their development.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

Researchers discovered potential origins and new treatments for skin cancer, including biomarkers for melanoma and therapies that reduce tumor growth.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

T cell subsets are crucial in kidney cancer, and a new model predicts patient outcomes using key genes.

Kremen is crucial for proper development and preventing tumors by regulating Wnt signaling.

HPV8 causes skin cancer by expanding specific skin stem cells.

Certain genetic variants increase the risk of aggressive prostate cancer.

Targeted cancer therapies can cause skin side effects, but activating SOS in the skin may help reduce them.

Coinheritance of BRCA2 and CYLD genes may lead to new treatment options for certain cancers.

ATP-sensitive K+ channel subunits, particularly Sur2A, play a significant role in various cancers.

Keratin 15 cells from hair follicles help develop and maintain skin tumors in mice.

Deleting vitamin D and calcium receptors in skin cells increases skin cancer risk by reducing DNA repair and stress response.

Older skin has higher cancer risk due to inflammation and stem cell issues.

ETS2 drives cancer progression in squamous cell carcinoma and is linked to poor patient outcomes.

Recent findings advanced understanding of cancer mechanisms and potential treatments.

Some brain cancer cells avoid immune system detection, and certain treatments could target this to slow their growth; also, certain fat cell precursors help regenerate hair and skin after injury.